Folwarczna Joanna, Janiec Waldemar, Gawor Marta, Pytlik Maria, Kaczmarczyk-Sedlak Ilona, Nowińska Barbara
Department of Pharmacology, Medical University of Silesia, Jagiellońska 4, PL 41-200 Sosnowiec, Poland.
Pol J Pharmacol. 2004 Jul-Aug;56(4):451-7.
Enoxaparin sodium is a low-molecular-weight heparin. It is not clear whether the risk of development of osteoporosis after administration of low-molecular-weight heparins is lower than after administration of standard heparin. The aim of the present study was to investigate the effects of enoxaparin on histomorphometric parameters of bones in female Wistar rats (13-15 weeks old at the beginning of the experiment). Enoxaparin was administered at doses of 1000 anti-Xa IU/kg sc daily or 2000 anti-Xa IU/kg sc daily for 4 weeks. Bone mass, mineral and calcium content (in the tibia, femur and L-4 vertebra), length and diameter in the tibia and femur, and histomorphometric parameters of the tibia (periosteal and endosteal transverse growth, width of periosteal and endosteal osteoid, area of the transverse cross-section of the cortical bone in the diaphysis and area of the transverse cross-section of the marrow cavity) and the femur (width of epiphyseal and metaphyseal trabeculae, width of epiphyseal cartilage) were examined. Enoxaparin, administered at doses of 1000 anti-Xa IU/kg sc daily or 2000 anti-Xa IU/kg sc daily for 28 days, induced osteopenic changes in the rat skeletal system. The changes observed in bone histomorphometric parameters indicate that enoxaparin caused the inhibition of bone formation and intensification of bone resorption.
依诺肝素钠是一种低分子量肝素。目前尚不清楚低分子量肝素给药后骨质疏松症的发生风险是否低于标准肝素给药后。本研究的目的是调查依诺肝素对雌性Wistar大鼠(实验开始时13 - 15周龄)骨骼组织形态计量学参数的影响。依诺肝素以1000抗Xa国际单位/千克皮下注射每日一次或2000抗Xa国际单位/千克皮下注射每日一次的剂量给药4周。检测了骨量、矿物质和钙含量(胫骨、股骨和L - 4椎体)、胫骨和股骨的长度和直径,以及胫骨(骨膜和骨内膜横向生长、骨膜和骨内膜类骨质宽度、骨干皮质骨横截面积和骨髓腔横截面积)和股骨(骨骺和干骺端小梁宽度、骨骺软骨宽度)的组织形态计量学参数。依诺肝素以1000抗Xa国际单位/千克皮下注射每日一次或2000抗Xa国际单位/千克皮下注射每日一次的剂量给药28天,可引起大鼠骨骼系统的骨质减少变化。观察到的骨组织形态计量学参数变化表明,依诺肝素导致骨形成受到抑制,骨吸收增强。